Excluding Early T2D Cases (within 1 year of baseline), N = 32,967, 294 T2D cases
|
NMF Component 1
|
1
|
1.35 (0.93, 1.97)
|
1.35 (0.92, 1.99)
|
1.44 (0.98, 2.12)
|
1.50 (0.99, 2.27)
|
0.06
|
NMF Component 2
|
1
|
1.05 (0.72, 1.52)
|
0.99 (0.68, 1.45)
|
1.03 (0.70, 1.52)
|
1.19 (0.79, 1.77)
|
0.49
|
NMF Component 3
|
1
|
1.06 (0.70, 1.60)
|
1.18 (0.85, 1.64)
|
1.01 (0.73, 1.41)
|
0.90 (0.59, 1.37)
|
0.78
|
NMF Component 4
|
1
|
1.09 (0.71, 1.66)
|
1.10 (0.79, 1.53)
|
1.16 (0.83, 1.63)
|
0.83 (0.58, 1.20)
|
0.51
|
Excluding CVDa cases before or during follow-up, N = 32,773, 235 T2D cases
|
NMF Component 1
|
1
|
1.34 (0.94, 1.91)
|
1.55 (1.09, 2.22)
|
1.50 (1.04, 2.16)
|
1.47 (0.99, 2.18)
|
0.04
|
NMF Component 2
|
1
|
0.97 (0.68, 1.39)
|
1.06 (0.75, 1.51)
|
1.15 (0.80, 1.65)
|
1.11 (0.76, 1.63)
|
0.39
|
NMF Component 3
|
1
|
0.91 (0.61, 1.35)
|
1.07 (0.79, 1.46)
|
1.02 (0.75, 1.38)
|
0.87 (0.59, 1.29)
|
0.79
|
NMF Component 4
|
1
|
1.04 (0.70, 1.54)
|
0.99 (0.73, 1.35)
|
1.06 (0.77, 1.45)
|
0.83 (0.59, 1.16)
|
0.27
|
Excluding metabolic abnormalitiesb at baseline, N = 24,962, 129 T2D cases
|
NMF Component 1
|
1
|
1.41 (0.75, 2.64)
|
2.17 (1.19, 3.95)
|
1.82 (0.98, 3.39)
|
1.81 (0.93, 3.52)
|
0.05
|
NMF Component 2
|
1
|
0.65 (0.36, 1.18)
|
0.87 (0.50, 1.54)
|
1.12 (0.65, 1.94)
|
1.17 (0.66, 2.07)
|
0.22
|
NMF Component 3
|
1
|
1.18 (0.65, 2.14)
|
0.95 (0.56, 1.61)
|
0.97 (0.58, 1.63)
|
1.11 (0.61, 2.01)
|
0.86
|
NMF Component 4
|
1
|
1.23 (0.66, 2.30)
|
1.57 (0.95, 2.59)
|
1.14 (0.66, 1.98)
|
1.20 (0.69, 2.07)
|
0.74
|